Jacek Olczak, Philip Morris CEO (AP Images)
Philip Morris bags another biotech as bidding war with Carlyle over Vectura deal heats up
In one of the more unlikely bidding wars in recent biopharma memory, a British tobacco giant and a US private equity firm are competing to …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
